Community/Retail

The designation was based on data from 7 clinical trials over the past decade, which assessed omalizumab’s efficacy and safety versus various food allergens, such as peanut, milk, and egg.

Officials with the FDA have approved migalastat (Galafold, Amicus Therapeutics), the first oral medication for the treatment of adults with Fabry disease.

Canine animal assistance improves attentiveness and social skills in children with ADHD, according to recent study.

The FDA has approved a combined hormonal contraceptive for women that is the first vaginal ring contraceptive that can be used for an entire year.

Officials with the FDA have approved the first targeted treatment for adult patients with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis, a rare and often fatal disease.

The FDA has permitted marketing of Natural Cycles, the first mobile medical app that can be used as a method of contraception to prevent pregnancy.

As health care providers work to combat the growing abuse epidemic, the results of a new study suggest that interventions using behavioral insights can change the course of care.

This action, aimed at saving patients money, is part of the Trump administration’s larger agenda to create competition among medications that treat the same conditions.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The program recognizes over 30 exceptional pharmacy professionals in 10 categories.

The FDA has approved updates to the labeling for hepatitis C virus (HCV) drug glecaprevir and pibrentasvir (Mavyret) to include new data from 2 clinical studies.

The FDA has approved several strengths of Apotex Inc.’s potassium chloride oral solution as the first generic drugs to receive a Competitive Generic Therapy designation.

Officials with the FDA have approved a new treatment for 2 rare types of non-Hodgkin lymphoma of the skin, relapsed or refractory mycosis fungoides and Sézary syndrome, after at least 1 prior systemic therapy.

Ned Milenkovich, PharmD, JD, is chairman of the health care law practice at Much Shelist PC in Chicago, and former vice chairman of the Illinois State Board of Pharmacy. In this video, he discusses hemp regulation.

A recent study found that athletes with attention deficit hyperactivity disorder (ADHD) may need to be even more cautious in concussion prevention.

The agency has amended its list of drugs that contain the ingredient, which is used to treat high blood pressure and heart failure.

Officials with the FDA have updated the label of lumacaftor/ivacaftor (Orkambi, Vertex Pharmaceuticals), approving the treatment's use in children aged 2 to 5 years old.

The FDA is encouraging the development of novel medication-assisted treatment drugs for individuals with opioid use disorder (OUD), while the first non-opioid medication indicated for the reduction of opioid withdrawal symptoms has been made available to the market.

How you organize your pharmacy’s business to create significantly more success is what this article is all about.

Pharmacists can play an important role in medication management, and prevention strategies for low back pain.

Staying up to date with vaccinations is crucial in preventing children and their classmates from getting sick.

In this clip, Kimberly Wu, a PharmD candidate at the Rutgers University Ernest Mario School of Pharmacy, discusses why it is important for pharmacy students to get involved in student organizations.

Few young women develop venous thromboembolism, but 2 circumstances increase risk in women of childbearing age: pregnancy, and the use of sex hormones, including oral contraceptives.

Howard Cohen, RPh, MS, FASHP, from Smilow Cancer Hospital at Yale-New Haven Health, explains how health systems can utilize information technology as a tool to address the challenges of oral chemotherapies.

New research demonstrates continued virologic control in patients with HIV-1 following a switch to Symtuza (darunavir 800 mg, cobicistat 150 mg, emtricitabine 200 mg, and tenofovir alafenamide 10 mg [D/C/F/TAF]) regardless of prior treatment regimen

Clinicians generally have 2 options for women who develop endometriosis: surgery or medical therapies. The goal is to address active symptoms, prevent recurrence, and control pain.